أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain spinal stungulyf, lausn 5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain spinal tung stungulyf, lausn 5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain stungulyf, lausn 2,5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 2,5 mg/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain stungulyf, lausn 5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain adrenalin stungulyf, lausn 2,5 mg/ml+5 míkróg/m
aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 2,5 mg/ml+5 míkróg/m
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
marcain adrenalin stungulyf, lausn 5 mg/ml+5 míkróg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 5 mg/ml+5 míkróg/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
exagon vet. (exagon 400) stungulyf, lausn 400 mg/ml
vetviva richter gmbh - pentobarbitalum natríum - stungulyf, lausn - 400 mg/ml
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Æxlishemjandi lyf - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
raplixa
mallinckrodt pharmaceuticals ireland limited - mannafíbrógen manna, trombín manna - hemostasis, skurðaðgerð - antihemorrhagics - stuðningsmeðferð þar sem venjulegar skurðaðgerðir eru ekki nægjanlegar til að bæta blóðflæði. raplixa verður að nota í ásamt samþykkt gelatín svampur. raplixa er ætlað í fullorðnir yfir 18 ára aldri.
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
prid delta leggangainnlegg 1,55 g
ceva santé animale* - progesteronum inn - leggangainnlegg - 1,55 g